v3.26.1
Stockholders' Equity - Schedule of Non-vested Restricted Stock Units (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2026
Time-Based Shares    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance (in shares)   4,350,213
Granted (in shares)   1,789,977
Vested (in shares)   (1,731,759)
Forfeited (in shares)   (141,038)
Ending balance (in shares) 4,350,213 4,267,393
Performance- Based Shares    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance (in shares)   2,299,186
Granted (in shares)   895,332
Vested (in shares)   (8,729)
Forfeited (in shares)   (150,479)
Ending balance (in shares) 2,299,186 3,035,310
Non-Vested Restricted Stock Units    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance (in shares)   6,649,399
Granted (in shares)   2,685,309
Vested (in shares)   (1,740,488)
Forfeited (in shares)   (291,517)
Ending balance (in shares) 6,649,399 7,302,703
Expected to vest (in shares)   7,302,703
Weighted- Average Grant-Date Fair Value    
Beginning balance (in dollars per share)   $ 12.99
Granted (in dollars per share)   12.24
Vested (in dollars per share)   15.22
Forfeited (in dollars per share)   16.62
Ending balance (in dollars per share) $ 12.99 11.72
Expected to vest (in dollars per share)   $ 11.72
Weighted- Average Remaining Contractual Term (years)    
Weighted- Average Remaining Contractual Term (years)
Expected to vest (in years)   1 year 2 months 26 days
Aggregate Intrinsic Value (in thousands)    
Beginning balance  
Ending balance
Expected to vest   $ 82,594